Evidence map›Paper›PMID 37675689›Full record

ArticleThe Indian journal of medical research2023

Determinants of post discharge mortality among hospitalized COVID-19 patients.

Gunjan Kumar, Arunansu Talukdar, Alka Turuk, Ashish Bhalla, Subhasis Mukherjee, Pankaj Bhardwaj, Tarun Bhatnagar, Aparna Mukherjee

Open access · diamondAbstract read
In one paragraph

Article in The Indian journal of medical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Gunjan KumarClinical Studies & Trials Unit, Indian Council of Medical Research, New Delhi, India.
Arunansu TalukdarDepartment of Geriatric Medicine, Medical College & Hospital, Kolkata, West Bengal, India.
Alka TurukClinical Studies & Trials Unit, Indian Council of Medical Research, New Delhi, India.
Ashish BhallaDepartment of Internal Medicine, Institute of Medical Education & Research, Chandigarh, India.
Subhasis MukherjeeDepartment of Respiratory Medicine, College of Medicine & Sagore Dutta Hospital, Kolkata, West Bengal, India.
Pankaj BhardwajDepartment of Community Medicine and Family Medicine, School of Public Health, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Tarun BhatnagarSchool of Public Health, ICMR-National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Aparna MukherjeeClinical Studies & Trials Unit, Indian Council of Medical Research, New Delhi, India.
Indian Council of Medical Research · INAll India Institute of Medical Sciences Jodhpur · INCollege of Medicine & Sagore Dutta Hospital · INMedical College and Hospital, Kolkata · INNational Institute of Epidemiology · INPost Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & objectives: The post-acute effects of COVID-19 are continually being updated. This investigation was conducted to evaluate the determinants of post discharge mortality in hospitalized COVID-19 patients, especially 18-45 yr of age. Methods: A series of three nested case-control analyses was conducted on follow up data collected in the National Clinical Registry for COVID-19 between September 2020 and February 2023 from 31 hospitals. Matching (1:4) was done by the date of hospital admission ±14 days for the following comparisons: (i) case-patients reported as dead vs. controls alive at any contact within one year follow up; (ii) the same in the 18-45 yr age group and (iii) case-patients reported as dead between the first and one year of follow up vs. controls alive at one year post discharge. Results: The one year post discharge mortality was 6.5 per cent (n=942). Age [≤18 yr: adjusted odds ratio (aOR) (95% confidence interval [CI]): 1.7 (1.04, 2.9); 40-59 yr: aOR (95% CI): 2.6 (1.9, 3.6); ≥60 yr: aOR (95% CI): 4.2 (3.1, 5.7)], male gender [aOR (95% CI): 1.3 (1.1, 1.5)], moderate-to-severe COVID-19 [aOR (95% CI): 1.4 (1.2, 1.8)] and comorbidities [aOR (95%CI): 1.8 (1.4, 2.2)] were associated with higher odds of post-discharge one-year mortality, whereas 60 per cent protection was conferred by vaccination before the COVID-19 infection. The history of moderate-to-severe COVID-19 disease [aOR (95% CI): 2.3 (1.4, 3.8)] and any comorbidities [aOR (95% CI): 3 (1.9, 4.8)] were associated with post-discharge mortality in the 18-45-yr age bracket as well. Post COVID condition (PCC) was reported in 17.1 per cent of the participants. Death beyond the first follow up was associated with comorbidities [aOR (95%CI): 9.4 (3.4, 26.1)] and reported PCC [aOR (95% CI): 2.7 (1.2, 6)]. Interpretation & conclusions: Prior vaccination protects against post discharge mortality till one year in hospitalized COVID-19 patients. PCC may have long term deleterious effects, including mortality, for which further research is warranted.

Indexed as

COVID-19AftercareHospitalizationHumansMalePatient DischargePost-Acute COVID-19 SyndromeIndiaobservational studyone-year mortalitypersistent symptomspost-acute COVID symptoms

Identifiers

PMID37675689
PMCPMC10645026
OpenAlexW4386229008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.